The Claim

In glucose-deprived A549 lung adenocarcinoma cells, inhibition of AMPK activity reduces SLC38A2 expression, glutamine utilization, glycolysis, and malignant behaviors, while AMPK activation rescues these effects even under PCK2 suppression, demonstrating that AMPK is a necessary downstream mediator of PCK2’s metabolic effects.

Source: Phosphoenolpyruvate carboxykinase 2 activation of the AMPK–CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
48score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In lung cancer cells deprived of glucose, reducing AMPK activity decreases SLC38A2 expression, glutamine use, glycolysis, and cancer-like behaviors; activating AMPK restores these processes even when PCK2 is blocked, showing AMPK is required for PCK2 to control these metabolic functions.

See the scientific wording

In glucose-deprived A549 lung adenocarcinoma cells, inhibition of AMPK activity reduces SLC38A2 expression, glutamine utilization, glycolysis, and malignant behaviors, while AMPK activation rescues these effects even when PCK2 is suppressed, indicating AMPK is a necessary downstream mediator of PCK2’s metabolic effects.

Why this might work

When sugar is scarce, a protein called PCK2 turns on AMPK, which activates another protein called CEBPB. CEBPB then tells the cell to make more of a transporter that pulls glutamine inside. Glutamine feeds into energy production pathways that keep glycolysis running and provide building blocks for cell growth. This allows cancer cells to keep multiplying, moving, and surviving even without sugar.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Phosphoenolpyruvate carboxykinase 2 activation of the AMPK–CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation

    When lung cancer cells are starved of sugar, they use glutamine for energy, and a protein called AMPK helps turn on this process. Even though another protein (PCK2) starts the chain, the study shows AMPK is the key switch—without it, the cells can’t grow, even if PCK2 is active.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.